Yes it’s great news to have these kinds of observations and outcomes published in a medical journal. Only two kids and not a proper trial, but the observations made are priceless. Won’t move the SP as we already knew about this some time back, but good to see the confidence building among health and medical professionals.
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-141
-
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.005(0.43%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $1.618M | 1.381M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 13110 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 15810 | 6 |
View Market Depth
| Last trade - 11.23am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |